CIK: 0001609251 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 17, 2021
Total Value ($000): $342,426 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALEXION PHARMACEUTICALS INC | 364,274 | $56,914 | 16.6% | $97.60 | — | COM | 015351109 |
| UTHR | UNITED THERAPEUTICS CORP | 322,537 | $48,958 | 14.3% | $121.76 | +7.8% | COM | 91307C102 |
| — | TARO PHARMACEUTICAL INDUS | 553,646 | $40,649 | 11.9% | $78.11 | — | COM | M8737E108 |
| REGN | REGENERON PHARMACEUTICALS | 82,200 | $39,712 | 11.6% | $342.96 | +56.5% | COM | 75886F107 |
| ENTA | ENANTA PHARMACEUTICALS INC | 858,811 | $36,156 | 10.6% | $44.29 | -0.7% | COM | 29251M106 |
| BIIB | BIOGEN INC | 138,017 | $33,795 | 9.9% | $311.05 | -16.7% | COM | 09062X103 |
| ALKS | ALKERMES PLC | 1,620,675 | $32,332 | 9.4% | $18.60 | -1.7% | COM | G01767105 |
| MCK | MCKESSON CORP | 166,983 | $29,042 | 8.5% | $138.18 | +16.8% | COM | 58155Q103 |
| — | SURGALIGN HOLDINGS INC | 6,423,408 | $14,067 | 4.1% | $1.82 | — | COM | 86882C105 |
| — | INVACARE CORP | 904,547 | $8,096 | 2.4% | $11.95 | — | COM | 461203101 |
| ANAB | ANAPTYSBIO INC | 110,448 | $2,375 | 0.7% | $23.65 | +2.7% | COM | 032724106 |
| — | NEXTCURE INC | 30,292 | $330 | 0.1% | $10.89 | — | COM | 65343e108 |